{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03592849",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SC201700101"
      },
      "Organization": {
        "OrgFullName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring",
      "OfficialTitle": "The Efficacy and Safety of Collagen Scaffold Loaded With Umbilical Cord Derived Mesenchymal Stem Cells in Infertile Women With Thin Endometrium or Endometrial Scarring"
    },
    "StatusModule": {
      "StatusVerifiedDate": "August 2021",
      "OverallStatus": "Enrolling by invitation",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 10, 2018",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "January 31, 2021",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "December 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "July 9, 2018",
      "StudyFirstSubmitQCDate": "July 9, 2018",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "July 19, 2018",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "August 31, 2021",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "September 1, 2021",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Yali Hu",
        "ResponsiblePartyInvestigatorTitle": "Professor，Chief Physician of Obstetrics and Gynecology",
        "ResponsiblePartyInvestigatorAffiliation": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School"
      },
      "LeadSponsor": {
        "LeadSponsorName": "The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "The purpose of the study is to evaluate the safety and effectiveness of the collagen scaffold loaded with umbilical cord derived mesenchymal stem cells (UC-MSCs) in infetile women with thin endometrium or endometrial scarring."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Infertility, Female",
          "Endometrium"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "thin endometrium",
          "infertility"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "50",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "UC-MSCs therapy",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "transplant collagen scaffold loaded with UC-MSCs to treat infertility caused by thin endometrium or endometrial scarring",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Procedure: UC-MSCs therapy"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Procedure",
            "InterventionName": "UC-MSCs therapy",
            "InterventionDescription": "After history taking, physical examination, ultrasound examination and hysteroscopy examination，infertile women diagnosed with thin endometrium or endometrial scarring will be included in the clinical trial. A collagen scaffold loaded with UC-MSCs will be transplanted into the uterine cavity during hysteroscopy, and participants will receive hormone replacement therapy before and after the treatment. Postoperative observations including ultrasound examination once a month for 3 times and hysteroscopy in the third month after first UC-MSCs therapy. Those whose endometrium is suitable for pregnancy will be recommended attempting conception actively. The next round of cell therapy will be conducted 3 cycles after the first month if the endometrial growth is unsatisfactory.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "UC-MSCs therapy"
              ]
            },
            "InterventionOtherNameList": {
              "InterventionOtherName": [
                "collagen scaffold"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "endometrial thickness",
            "PrimaryOutcomeDescription": "endometrium thickness evaluated by transvaginal sonography during late proliferating phase",
            "PrimaryOutcomeTimeFrame": "12 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "ongoing pregnancy rate",
            "SecondaryOutcomeDescription": "the presence of a living intrauterine fetus on TVU at the 12th week of gestation",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "live birth rate",
            "SecondaryOutcomeDescription": "a live born baby ≥28 weeks of gestation",
            "SecondaryOutcomeTimeFrame": "24 months"
          },
          {
            "SecondaryOutcomeMeasure": "endometrial blood flow",
            "SecondaryOutcomeDescription": "uterine blood flow evaluated by transvaginal sonography",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "OtherOutcomeList": {
        "OtherOutcome": [
          {
            "OtherOutcomeMeasure": "menstrual blood volume",
            "OtherOutcomeDescription": "the change of menstrual blood volume after surgery compared with pre-operation",
            "OtherOutcomeTimeFrame": "baseline and 6 month postoperation"
          },
          {
            "OtherOutcomeMeasure": "adverse event rate",
            "OtherOutcomeDescription": "the occurrence of infections、allergies、abdominal pain postoperation",
            "OtherOutcomeTimeFrame": "30 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nInfertile patients with clear fertility desires\nDiagnosed with thin endometrium or endometrial scarring for whom drugs and surgical interventions were ineffective\n20-42 years old\nNormal ovarian function or with frozen embryos\nWilling to actively cooperate with postoperative follow-up\n\nExclusion Criteria:\n\nWith abnormal chromosome karyotype\nWith other uterine diseases including large intramural myomas, severe endometriosis, severe adenomyosis, severe congenital uterine malformations, endometrial tuberculosis, vaginitis and endometritis\nSystemic diseases: hypertension, diabetes, and so on\nContraindications to pregnancy\nContraindications to hormone replacement therapy\nMedical history of pelvic tumors or receiving pelvic radiotherapy\nInvolved in other clinical studies\nUnable to adhere to the follow-up",
      "HealthyVolunteers": "No",
      "Gender": "Female",
      "GenderBased": "Yes",
      "GenderDescription": "female",
      "MinimumAge": "20 Years",
      "MaximumAge": "42 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Yali Hu, MD,PhD",
            "OverallOfficialAffiliation": "The Affiliated Drum Tower Hospital of Nanjing University Medical School",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "Nanjing Drum Tower Hospital",
            "LocationCity": "Nanjing",
            "LocationState": "Jiangsu",
            "LocationZip": "210008",
            "LocationCountry": "China"
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No",
      "IPDSharingDescription": "Within six months after the trial complete"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000007246",
            "ConditionMeshTerm": "Infertility"
          },
          {
            "ConditionMeshId": "D000007247",
            "ConditionMeshTerm": "Infertility, Female"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M9442",
            "ConditionBrowseLeafName": "Infertility",
            "ConditionBrowseLeafAsFound": "Infertility",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M9443",
            "ConditionBrowseLeafName": "Infertility, Female",
            "ConditionBrowseLeafAsFound": "Infertility, Female",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M5312",
            "ConditionBrowseLeafName": "Cicatrix",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BXS",
            "ConditionBrowseBranchName": "Urinary Tract, Sexual Organs, and Pregnancy Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M8941",
            "InterventionBrowseLeafName": "Hormones",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}